These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2427907)

  • 1. Possible role of calmodulin in the control of histamine release from human basophil leukocytes.
    Marone G; Columbo M; Poto S; Giugliano R; Condorelli M
    Life Sci; 1986 Sep; 39(10):911-22. PubMed ID: 2427907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of calmodulin in the control of lysosomal enzyme release from human polymorphonuclear leukocytes.
    Marone G; Poto S; Columbo M; Giugliano R; Genovese A; Condorelli M
    J Pharmacol Exp Ther; 1984 Dec; 231(3):678-84. PubMed ID: 6502522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of histamine release from human basophils in vitro by calmodulin antagonists.
    Marone G; Columbo M; Poto S; Condorelli M
    Clin Immunol Immunopathol; 1983 Sep; 28(3):334-40. PubMed ID: 6192958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G
    J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionic regulation of human basophil releasability. III. Effects of Na+ and Ca2+ on histamine release induced by different stimuli.
    Tedeschi A; Palella M; Arquati M; Milazzo N; Miadonna A
    Pharmacol Res; 1994; 30(3):229-41. PubMed ID: 7532302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of hypertonicity on FMLP-, anti-IgE- and Ca2+ ionophore A23187-induced histamine release from human basophil leukocytes.
    Tedeschi A; Arquati M; Lorini M; Miadonna A
    Int Arch Allergy Appl Immunol; 1990; 93(4):359-64. PubMed ID: 1713571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis-trans isomerase in a secretagogue specific manner.
    Bergstrand H; Lundquist B
    Allergy; 1992 Aug; 47(4 Pt 2):353-61. PubMed ID: 1280915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3).
    Ezeamuzie CI; Assem ES
    Immunopharmacology; 1990; 20(1):31-43. PubMed ID: 1699910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 5-lipoxygenase pathway activation in basophil histamine release.
    Morita Y; Suzuki S; Miyamoto T
    Int Arch Allergy Appl Immunol; 1985; 78(1):77-80. PubMed ID: 2411671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of human basophil histamine release by interleukin 5.
    Hirai K; Yamaguchi M; Misaki Y; Takaishi T; Ohta K; Morita Y; Ito K; Miyamoto T
    J Exp Med; 1990 Nov; 172(5):1525-8. PubMed ID: 1700056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of phospholipase A2 activation in histamine release from human basophils.
    Morita Y; Aida N; Miyamoto T
    Allergy; 1983 Aug; 38(6):413-8. PubMed ID: 6194706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine.
    Kleine-Tebbe J; Josties C; Frank G; Stalleicken D; Buschauer A; Schunack W; Kunkel G; Czarnetzki B
    J Allergy Clin Immunol; 1994 Feb; 93(2):494-500. PubMed ID: 7509820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
    de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
    J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc.
    Marone G; Findlay SR; Lichtenstein LM
    J Pharmacol Exp Ther; 1981 May; 217(2):292-8. PubMed ID: 6164779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of the H1 antagonist loratadine on histamine release from human basophils.
    Miadonna A; Milazzo N; Lorini M; Marchesi E; Tedeschi A
    Int Arch Allergy Immunol; 1994 Sep; 105(1):12-7. PubMed ID: 7522069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin antagonists enhance calcium binding to calmodulin.
    Inagaki M; Tanaka T; Hidaka H
    Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of basophil histamine release induced by pepstatin A.
    Marone G; Columbo M; Soppelsa L; Condorelli M
    J Immunol; 1984 Sep; 133(3):1542-6. PubMed ID: 6205086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auranofin, an oral chrysotherapeutic agent, inhibits histamine release from human basophils.
    Takaishi T; Morita Y; Kudo K; Miyamoto T
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 1):296-301. PubMed ID: 6206106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.